Roquefort Therapeutics plc (LON:ROQ)

London flag London · Delayed Price · Currency is GBP · Price in GBX
2.300
0.00 (0.00%)
Feb 21, 2025, 3:46 PM BST
-70.32%
Market Cap 3.12M
Revenue (ttm) n/a
Net Income (ttm) -1.54M
Shares Out 135.74M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 52,971
Average Volume 2,090,395
Open 2.280
Previous Close 2.300
Day's Range 2.204 - 2.300
52-Week Range 2.150 - 9.500
Beta -0.29
RSI 34.16
Earnings Date Apr 25, 2025

About Roquefort Therapeutics

Roquefort Therapeutics plc, a material biotech company, engages in the development of medicines for the treatment of cancer. Its product portfolio consists of five novel patent-protected pre-clinical anti-cancer medicines, which include Midkine antibodies with significance in vivo efficacy, toxicology studies, and orphan drug indication; Midkine RNA oligonucleotide therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics for solid tumors; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo effica... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Employees 10
Stock Exchange London Stock Exchange
Ticker Symbol ROQ
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.